Table 1.
Baseline profile of the study subjects
| Parameter | Mebeverine group (n=20) | Placebo group (n=20) | p |
|---|---|---|---|
| Age (years) | 0.236 | ||
| Range | 16 - 53 | 21 - 60 | |
| Mean±SD | 33.65±9.60 | 37.6±11.09 | |
| Gender | 0.065 | ||
| Male: Female | 8:12 | 2:18 | |
| Residence | 0.523 | ||
| Rural : Urban | 13 : 7 | 10 : 10 | |
| Duration of IBS (months) | 0.675 | ||
| Range | 6.0 - 60.0 | 6.0 - 60.0 | |
| Mean±SD | 19.7±13.16 | 21.7±19.01 | |
| Median (IQR) | 32.0 (38.5 - 29.2) | 35.0 (44.8 - 32.0) |
Abbreviations: IBS=Irritable bowel syndrome, IQR=Interquartile range; SD=Standard deviation. p value in the last column is from Student’s unpaired t test for age, from Mann-Whitney U test for symptom duration and Fisher’s exact test for gender and residence distribution